COVID-19 Business Update – Lab Reopens

COVID-19 Business Update – Lab Reopens

COVID-19 Business Update – Lab Reopens We would like to update our customers on our business operations following our decision to temporarily close the main HistologiX Lab from 25th March amid the COVID-19 outbreak. In line with the recent Government guidance in...
Advance your COVID-19 Research

Advance your COVID-19 Research

Advance your COVID-19 Research Gain deeper insights into your COVID-19 research with our integrated package from Tissue Solutions and HistologiX.   Our experts will source COVID-19 positive tissue in FFPE blocks and analyse them using ACD Bio-Techne’s...
Covid-19 Business Update

Covid-19 Business Update

Covid-19 Business Update We would like to update our customers amid the ever-changing COVID-19 virus outbreak. To play our part in stopping the virus in its tracks, we have decided to temporarily close the main HistologiX Ltd. Lab from 25th March until further notice...
Covid-19 Business Update

COVID-19 and business continuity

COVID-19 and business continuity We would like to reassure you that it is business as usual and provide an update regarding our response to the outbreak of the COVID-19 virus as well as our commitment to serving you and your critically important work moving forward....
Scientific expertise – innovative culture – integrity

Scientific expertise – innovative culture – integrity

Scientific expertise – innovative culture – integrity As a company, we want to have a clear idea of why we are doing what we do – what our reason for being is.  To this end we have formulated a mission statement.  We hope you will agree that it...
Immunotherapy of Cancer Conference

Immunotherapy of Cancer Conference

        Immunotherapy of Cancer Conference   3rd-5th Oct, 2020 Munich, Germany Booth Number: TBC By ITOC Association    3-5th Oct, 2020  Event The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich,...